Angerer Silvia, Glätzle-Rützler Daniela, Lergetporer Philipp, Rittmannsberger Thomas
UMIT TIROL, Private University for Health Sciences and Health Technology, Hall in Tirol.
University of Innsbruck.
Eur Econ Rev. 2023 Jun 7:104504. doi: 10.1016/j.euroecorev.2023.104504.
People's willingness to vaccinate is critical to combating the COVID-19 pandemic. We devise a representative experiment to study how the design of the vaccine approval procedure affects trust in newly developed vaccines and consequently public attitudes towards vaccination. Compared to an , choosing the more thorough approval procedure increases vaccination intentions by 13 percentage points. The effects of the increased duration of the approval procedure are positive and significant only for . Treatment effects do not differ between relevant subgroups, such as respondents who had (did not have) COVID-19, or between vaccinated and unvaccinated respondents. Increased trust in the vaccine is the key mediator of treatment effects on vaccination intentions.
人们接种疫苗的意愿对于抗击新冠疫情至关重要。我们设计了一项具有代表性的实验,以研究疫苗审批程序的设计如何影响对新研发疫苗的信任,进而影响公众对疫苗接种的态度。与[此处原文缺失相关内容]相比,选择更全面的审批程序会使接种意愿提高13个百分点。审批程序延长的影响仅对[此处原文缺失相关内容]具有积极且显著的作用。在相关亚组之间,如感染过(未感染过)新冠的受访者之间,或已接种和未接种疫苗的受访者之间,治疗效果并无差异。对疫苗信任度的提高是治疗效果影响接种意愿的关键中介因素。